| |
| |
|
| Insider
Information: |
Perry Gregory D |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
33,551 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$69,272 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
33,551 |
|
|
| Total
Value |
$69,272 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunogen Inc |
IMGN |
Chief Financial Officer |
2013-09-10 |
0 |
2011-06-29 |
0 |
Premium* |
|
|
Invivo Therapeutics Holdings Cor... |
NVIV |
Interim CFO |
2013-12-30 |
22,374 |
2013-12-30 |
0 |
Premium* |
|
|
Novelion Therapeutics Inc |
NVLN |
See Remarks |
2017-05-09 |
1,683 |
2017-05-09 |
0 |
Premium* |
|
|
Kala Pharmaceuticals, Inc. |
KALA |
|
2023-06-22 |
9,494 |
2021-06-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KALA |
Kala Pharmaceuticals, Inc... |
|
– • – |
2023-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,956 |
9,494 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
|
– • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,738 |
2,538 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
|
– • – |
2021-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
40,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
See Remarks |
• – – |
2017-05-09 |
4 |
D |
$9.42 |
$6,688 |
D/D |
(710) |
1,683 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
See Remarks |
• – – |
2017-05-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,393 |
2,393 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
Interim CFO |
• – – |
2013-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
22,374 |
22,374 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2013-09-10 |
4 |
AS |
$17.82 |
$326,692 |
D/D |
(18,337) |
0 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2013-09-10 |
4 |
OE |
$4.32 |
$79,216 |
D/D |
18,337 |
18,337 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2011-11-15 |
4 |
OE |
$4.32 |
$35,999 |
D/D |
8,333 |
8,333 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2011-11-15 |
4 |
AS |
$12.58 |
$104,862 |
D/D |
(8,333) |
0 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2011-10-17 |
4 |
AS |
$13.40 |
$111,646 |
D/D |
(8,333) |
0 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2011-10-17 |
4 |
OE |
$4.32 |
$35,999 |
D/D |
8,333 |
8,333 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2011-09-26 |
4 |
OE |
$4.32 |
$35,999 |
D/D |
8,333 |
8,333 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2011-09-26 |
4 |
AS |
$11.00 |
$91,663 |
D/D |
(8,333) |
0 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2011-08-15 |
4 |
AS |
$11.06 |
$92,121 |
D/D |
(8,333) |
0 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2011-08-15 |
4 |
OE |
$4.32 |
$35,999 |
D/D |
8,333 |
8,333 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2011-07-15 |
4 |
AS |
$15.12 |
$126,020 |
D/D |
(8,333) |
0 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2011-07-15 |
4 |
OE |
$4.32 |
$35,999 |
D/D |
8,333 |
8,333 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2011-06-29 |
4 |
AS |
$12.07 |
$100,571 |
D/D |
(8,333) |
0 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2011-06-29 |
4 |
OE |
$4.32 |
$35,999 |
D/D |
8,333 |
8,333 |
0 |
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
